Status BTA

click to purchase

Our point-of-care products can only be purchased by individuals or organizations with a valid CLIA certification, and first-time orders may experience shipping delays until certification verification is complete. We apologize for any inconvenience and appreciate your understanding in complying with regulatory guidelines
SKU: 39025

A rapid test for the qualitative detection of bladder tumor-associated antigen in human urine.

The test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. The simple urine sample collection also allows for improved patient comfort. Because tumor markers can be used to assess the response of tumor treatment and for prognosis, rapid screening tests like the Status BTA product are very helpful in the treatment management of cancer patients.

Product Specifications

Sample typeUrine specimen collection
Time to results5 minutes
MonitoringSensitivity 67% / Specificity 70% 
Kit contents(25) test devices, (25) transfer pipettes, Package insert
Storage35-86°F (2-30°C)
CLIA complexityWaived


More Information